# INOLYSIS jobs and careers

> 0 open roles at INOLYSIS as of October 24, 2026. Source: https://www.thejobsmap.com/company/inolysis

INOLYSIS is a new company founded in 2025 focusing on the development of novel drugs that target fibroblasts to mitigate chronic inflammation, fibrosis and cancer. The company builds on previous research that has identified several compounds effectively disrupting pathogenic fibroblast activation. By targeting fibroblasts - an underexplored yet central driver of disease pathogenesis-, INOLYSIS is pioneering a new approach to treat chronic inflammatory and fibrotic diseases. Our innovative small molecules address the root causes of fibrotic and inflammatory conditions, offering new hope where current treatments fall short. Backed by cutting-edge science and a deep understanding of fibroblast biology, we are employing a multidisciplinary pipeline to develop novel therapeutics designed to halt disease progression and restore tissue health. With a strong foundation in translational research and a commitment to clinical impact, we aim to redefine the standard of care in fibrosis and related diseases.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Headquarters | Greece |
| Employees | 1 to 10 |
| Website | https://inolysis.com |

## Common questions

### Is INOLYSIS hiring right now?

INOLYSIS has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on INOLYSIS's careers site.

### Where is INOLYSIS headquartered?

INOLYSIS is headquartered in Greece.

### How do I apply for a job at INOLYSIS?

Pick a role on INOLYSIS's TheJobsMap page and select Apply. Every listing links to the original posting on INOLYSIS's own careers site, so you apply directly with the employer.